The potential applications of operative laparoscopy have expanded with improvements in technology and instrumentation. With newly developed techniques to complete both pelvic and paraaottic lymph node dissection, the use of the laparoscope has increased in patients with pelvic malignancies. Gynecologic oncologists are currently incorporating the techniques of operative laparoscopy in the management of patients with cervical, endometxial, and ovarian cancer. Multicenter prospective clinical trials are necessary to further define the role of laparoscopy in gynecologic oncology.
Historically, the laparoscope has been used for diagnostic purposes and for sterilization procedures. Due to technologic advances, operative laparoscopy now plays a role in the management of a wide variety of benign gynecological conditions including ectopic pregnancy, endometriosis, pelvic pain, leiomyomata, and adnexal masses. Similarly, the role of operative laparoscopy in the management of malignant disease has expanded. With newly developed techniques to complete both pelvic and paraaortic lymph node dissection, the use of the laparoscope has increased in patients with pelvic malignancies. Gynecologic oncologists are currently incorporating the techniques of operative laparoscopy in the management of patients with cervical, endometrial, and ovarian cancer.
The main role for operative laparoscopy in women with gynecologic neoplasms is in surgical staging. The technique of laparoscopic pelvic lymph node dissection was first described in women with cervical carcinoma by Querleu et al. in 1991 (1). Subsequently, other investigators have reported on the safety and efficacy of this procedure in patients with cancers of the cervix, endometrium, and ovary (2) (3) (4) . Critical to the addition of laparoscopy to oncology was the development of techniques forparaaortic lymphadenectomy. For surgical staging to be complete, access to bilateral paraaortic nodal tissue is imperative (Fig. 1) (8) . The primary benefit of surgical staging is the ability to identify patients who may benefit from extended field irradiation. Although the value of surgical staging remains controversial, management decisions based on the information result in an improvement in survival in 2.5 to 7% of women whose cancer is surgically staged (8, 9) . Other advantages of surgical staging include the removal of bulky lymph nodes, removal of diseased adnexae, and ovarian transposition. Laparoscopic lymphadenectomy in cervical cancer patients is utilized in two clinical settings (10) . In patients with early stage disease (FIGO IA-IIA) that is suitable for radical hysterectomy, lymph node sampling is carried out before radical hysterectomy. Lymph nodes are assessed by frozen section and radical hysterectomy is performed if they are negative for malignancy. In patients with FIGO IB-IIA disease as many as 5 to 10% will have positive common iliac and paraaortic lymph nodes (11) . Therefore, laparoscopic sampling can save these patients from undergoing a laparotomy. If the lymph nodes are positive, the surgical staging is completed laparoscopically, and the patient is then treated with radiation therapy. In contrast, patients with advanced disease (FIGO lIB-IV) are surgically staged with laparoscopic pelvic and paraaortic lymphadenectomy. Removal of bulky, grossly positive lymph nodes can be carried out in the majority of these patients.
L.vmth node yield is adequate and compares with that of staging laparotomies (3, 10) . Radiation can then be tailored to disease extent. There is some concern that transperitoneal laparoscopic lymphadenectomy techniques may increase radiation-related enteric morbidity. However, animal studies indicate that transperitoneal laparoscopic procedures may not produce any more surgical adhesions than extraperitoneal procedures (12) . In addition, to the use of the laparoscope for surgical staging, there are case reports of laparoscopic radical hysterectomy and laparoscopically assisted radical vaginal hysterectomy (5, 13, 14) . It remains to be seen whether these procedures will be incorporated into current clinical practice.
Operative laparoscopy is also useful in the management of patients with malignancies of the uterine corpus. In It is clear that laparoscopic approaches to the management of gynecologic malignancies are feasible and provide exciting alternatives. However, the safety and efficacy of operative laparoscopy compared to laparotomy in this setting has not been carefully studied. Potential advantages include shorter operative time for some procedures, shorter recovery times, and less adhesion formation. These new surgical techniques need to be evaluated critically and compared to more traditional approaches. Currently, the GOG, a multicenter cooperative group, is conducting studies to evaluate the use ofoperative laparoscopy in the management of cervical, endometrial, and ovarian cancer patients. Multicenter prospective clinical trials like these are necessary to further define the role of laparoscopy in gynecologic oncology.
